Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes

    Access Status
    Fulltext not available
    Authors
    Barnett, N.
    Geelhoed, E.
    Davis, E.
    Jones, T.
    De Bock, M.
    Smith, G.
    Norman, Richard
    Date
    2016
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Barnett, N. and Geelhoed, E. and Davis, E. and Jones, T. and De Bock, M. and Smith, G. and Norman, R. 2016. The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes. Diabetes Technology and Therapeutics. 18: pp. A101.
    Source Title
    Diabetes Technology and Therapeutics
    ISSN
    1520-9156
    School
    Department of Health Policy and Management
    URI
    http://hdl.handle.net/20.500.11937/21907
    Collection
    • Curtin Research Publications
    Abstract

    Background and Aims: Diabetes Mellitus affects over 630 million people worldwide and is directly attributed to 1.5 mil- lion deaths annually. Few studies have been conducted to determine the cost-effectiveness of gold-standard type 1 diabetes treatment resulting in low uptake among countries that do not provide subsidised access to patients. Discrete choice experiments (DCE) are an innovative measurement tool applied in a number of fields, however their application in health treatment lags. DCEs can be used to explore preferences towards alter- native treatment options and to determine relative cost-effectiveness using a holistic measure of relative attributes in the decision-making process. Method: A literature review was undertaken to identify the application of discrete choice experiments to evaluate preferences in type 1 diabetes treatments. Search terms were restricted to studies on type 1 diabetes but were not limited on any other basis. Results: Three papers contained the terms ‘discrete choice experiment’ and ‘type 1 diabetes’ from relevant databases. At present there are no studies that analyse the cost-effectiveness of type 1 diabetes treatment using a discrete choice experiment methodology. Conclusion: A significant gap in the literature suggests there is scope for a discrete choice experiment to be conducted with patients and parents of children suffering from type 1 diabetes. An applied DCE would contribute valuable insights into the benefit measurement of gold-standard therapies and may improve access if cost-effectiveness is demonstrated

    Related items

    Showing items related by title, author, creator and subject.

    • Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity
      Chowdhury, E.; Ademi, Z.; Moss, J.; Wing, L.; Reid, Christopher (2015)
      Abstract: The objective of this study was to examine the cost-effectiveness of angiotensin-converting enzyme inhibitor (ACEI)-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly ...
    • Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity
      Chowdhury, E.; Ademi, Z.; Moss, J.; Wing, L.; Reid, Christopher (2015)
      OBJECTIVE: To examine the cost-effectiveness of angiotensin-converting enzyme inhibitor-based (ACEI) treatment compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as ...
    • Comparing the effectiveness and cost-effectiveness of alternative type 2 diabetes monitoring intervals in resource limited settings
      Mukonda, E.; Lesosky, M.; Sithole, S.; van der Westhuizen, D.J.; Rusch, J.A.; Levitt, N.S.; Myers, Bronwyn ; Cleary, S. (2024)
      Type 2 diabetes (T2D) represents a growing disease burden in South Africa. While glycated haemoglobin (HbA1c) testing is the gold standard for long-term blood glucose management, recommendations for HbA1c monitoring ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.